Related Articles
Thalidomide plus chemotherapy exhibit enhanced efficacy in the clinical treatment of T-cell non‑Hodgkin's lymphoma: A prospective study of 46 cases
Breast cancer after curative chemotherapy in non-Hodgkin's lymphoma: Examination of the role of drug resistance and retrospective comparison to the outcome of de novo breast cancer
VEDex (vincristine, epirubicin dexamethasone): an effective and well tolerated palliative chemotherapy regimen for non-Hodgkin's lymphoma.
Salvage therapy with mitoxantrone, etoposide, bleomycin and dexamethasone for refractory or relapsed aggressive non-Hodgkin's lymphoma patients with a poor performance status or comorbidity
Diagnostic value of medical thoracoscopy in malignant pleural effusion induced by non‑Hodgkin's lymphoma